ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
72 hedge funds and large institutions have $21.5M invested in Aralez Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-6
Holders Change %
-7.69%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
25
Closed
16
Calls
$88K
Puts
$159K
Net Calls
-$71K
Net Calls Change
-$345K
Top Buyers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$343K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$306K |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$270K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$159K |
| 5 |
BlackRock
New York
|
+$102K |
Top Sellers
| 1 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$5.33M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.26M |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$1.5M |
| 4 |
AC
Armistice Capital
New York
|
-$1.5M |
| 5 |
PP
Prospector Partners
Guilford,
Connecticut
|
-$483K |
